Rasio Therapeutics, Inc. — Form D
Rasio Therapeutics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-26. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-26
- Form: D
- Accession: 0001895690-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 2
- Date of first sale: 2021-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-422550
Issuer
- Name: Rasio Therapeutics, Inc.
- CIK: 0001895690
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1100 WICOMICO STREET, BALTIMORE, MD, 21230
- Phone: 6018180612
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Sujuan Ba | Director | Bethesda, MA |
| Raju Kucherlapati | Director | Houston, TX |
| Ken Malone | Director | Baltimore, MD |
| Ken Malone | Executive Officer | Baltimore, MD |
More